77 results
8-K
EX-99.1
DRRX
Durect Corp
7 Jun 23
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
9:00am
for the treatment of acute organ injuries and chronic liver diseases, today announced that it has completed enrollment in its Phase 2b AHFIRM clinical trial … acute organ injuries and chronic liver diseases.
About DURECT Corporation
DURECT is a biopharmaceutical company committed to transforming
8-K
EX-99.1
DRRX
Durect Corp
10 Apr 23
Company on track to report data from ongoing Phase 2b AHFIRM trial in 2H 2023
9:30am
of action provides further scientific rationale for developing larsucosterol for the treatment of certain acute organ injuries and chronic diseases.
About
8-K
EX-99.1
0t1gh91krj2
29 Jul 21
DURECT Corporation Announces Second Quarter 2021 Financial Results and Update of Programs
4:15pm
8-K
EX-99.1
s2387155badmvuiu
4 May 21
DURECT Corporation Announces First Quarter 2021 Financial Results and Update of Programs
4:16pm
8-K/A
EX-99.1
yq9 wnzsc
8 Mar 21
DURECT Corporation Announces Fourth Quarter and Full Year 2020 Financial Results and Update of Programs
4:30pm
8-K
EX-99.1
pulimazao
4 Mar 21
DURECT Corporation Announces Fourth Quarter and Full Year 2020 Financial Results and Update of Programs
4:15pm
8-K
EX-99.1
ypd2bkle 1mm19pvk
5 Jan 21
DURECT Corporation Appoints Two New Board Members
9:00am
8-K
EX-99.2
xst1tcf
5 Jan 21
DURECT Corporation Appoints Two New Board Members
9:00am
8-K
EX-99.1
8g9ep
16 Dec 20
DURECT Corporation Announces DUR-928 Granted FDA Fast Track Designation for Treatment of Alcoholic Hepatitis
9:15am
8-K
EX-99.1
4flajq73n6w7m txzn
7 Dec 20
DURECT Corporation to Sell its LACTEL® Absorbable Polymer Product Line to Evonik for $15 Million
12:06pm
8-K
EX-99.1
jbw3r9vf9x4sq
13 Nov 20
Other Events
4:46pm